Villanego, FlorentinoMazuecos, AuxiliadoraPérez-Flores, Isabel MMoreso, FrancescAndrés, AmadoJiménez-Martín, CarlosMolina, MaríaCanal, CristinaSánchez-Cámara, Luis AZárraga, SofíaRuiz-Fuentes, María Del CarmenAladrén, María JoséMelilli, EdoardoLópez, VerónicaSánchez-Álvarez, EmilioCrespo, MartaPascual, JulioSpanish Society of Nephrology COVID-19 Group2023-02-092023-02-092021-04-12http://hdl.handle.net/10668/17389SARS-CoV-2 infection has produced high mortality in kidney transplant (KT) recipients, especially in the elderly. Until December 2020, 1011 KT with COVID-19 have been prospectively included in the Spanish Registry and followed until recovery or death. In multivariable analysis, age, pneumonia, and KT performed ≤6 months before COVID-19 were predictors of death, whereas gastrointestinal symptoms were protective. Survival analysis showed significant increasing mortality risk in four subgroups according to recipient age and time after KT (age 6 months, age 6 and age ≥65 and time ≤6): mortality rates were, respectively, 11.3%, 24.5%, 35.4%, and 54.5% (p enclinical research/practiceinfection and infectious agents - viralkidney transplantation/nephrologypatient survivalAgedCOVID-19HumansInfantKidney TransplantationPandemicsRegistriesSARS-CoV-2Transplant Recipientsresearch article33756067open access10.1111/ajt.165791600-6143PMC8250925https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250925https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250925/pdf